NEW&Best seller

OxyContin®LP 40mg (Mundipharma) 🇬🇧

€230 – €1,480

OxyContin 40mg (Mundipharma Company Uk 🇬🇧)

Product Name and Active Ingredient

Brand Name:OxyContin® 40 mg

Generic Name:Oxycodone Hydrochloride

Drug Class:Opioid Analgesic

Dosage Form:Prolonged-Release Tablet (12-hour extended release)

Composition

Active Ingredient:Each tablet contains 40 mg of oxycodone hydrochloride (equivalent to 20 mg of oxycodone base)

Manufacturer and Country of Origin

Manufacturer: Mundipharma Pharmaceuticals Ltd. (previously Napp Pharmaceuticals)

Country of Origin: Ireland (EU)

2 Strips or 28 Tablets per 1 Box

#Oxy #Oxi #Perc #Percocet #Oxycodone #Morphine #Codeine #Dihydrocodeine #DHC #Dihydrocodein

size

Clear

SKU: N/A Category: (oxycodone hydrochloride 40mg /2 Strips or 28 Tablets per 1 Box) Tags: OXYCODONE, pill

Indications

Indicated for the management of moderate to severe pain requiring continuous, around-the-clock opioid treatment, such as chronic cancer pain or non-malignant chronic pain

Warnings and Precautions

**Addiction Risk: High potential for abuse and addiction; use in opioid-naïve patients can lead to fatal respiratory depression

**Concomitant Use with CNS Depressants: Combining with benzodiazepines or alcohol increases the risk of respiratory depression

**Use in Elderly or Hepatic/Renal Impairment: Dose adjustments and close monitoring are necessary

History and Development

**Developed by: Purdue Pharma L.P.

**Year Introduced: 1996

**Notable Feature: First extended-release oxycodone formulation providing 12-hour pain relief

Misuse and Societal Impact

**Misuse Methods: Reports of crushing, chewing, or injecting to achieve rapid onset, leading to increased addiction and overdose risks

**Societal Impact: Widespread misuse contributed to the opioid epidemic in the U.S., resulting in legal actions against Purdue Pharma for misleading marketing practices

Additional Information

**Reformulation: In 2010, the formulation was modified to include abuse-deterrent properties to prevent crushing and misuse

**Regulatory Status: Classified as a Schedule II controlled substance in the U.S., indicating high potential for abuse and strict regulatory controls